1. Home
  2. GSBC vs CSTL Comparison

GSBC vs CSTL Comparison

Compare GSBC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Southern Bancorp Inc.

GSBC

Great Southern Bancorp Inc.

HOLD

Current Price

$72.03

Market Cap

746.4M

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$21.66

Market Cap

597.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSBC
CSTL
Founded
1923
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
746.4M
597.8M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
GSBC
CSTL
Price
$72.03
$21.66
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$65.00
$45.50
AVG Volume (30 Days)
88.8K
491.9K
Earning Date
04-15-2026
05-06-2026
Dividend Yield
2.54%
N/A
EPS Growth
17.68
N/A
EPS
1.58
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
N/A
$2.42
Revenue Next Year
$2.56
$12.69
P/E Ratio
$44.96
N/A
Revenue Growth
N/A
3.66
52 Week Low
$53.76
$14.59
52 Week High
$73.12
$44.28

Technical Indicators

Market Signals
Indicator
GSBC
CSTL
Relative Strength Index (RSI) 60.90 51.89
Support Level $60.23 $17.72
Resistance Level N/A $22.18
Average True Range (ATR) 2.01 1.11
MACD 0.08 0.31
Stochastic Oscillator 81.44 87.84

Price Performance

Historical Comparison
GSBC
CSTL

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: